OmniTier
San Jose, California, United States
OmniTier develops AI-based multiomics appliances and software for bioinformaticians and clinical researchers, delivering affordable, end-to-end genomic analysis solutions. The company specializes in on-premise genomics analysis appliances that enable fast, scalable, and secure processing of whole genome and whole exome sequencing data from short-read (Illumina, MGI) and long-read (PacBio, Oxford Nanopore) sequencers. OmniTier's proprietary algorithms and workflows leverage advanced AI and data acceleration technologies to automate secondary and tertiary analysis, including variant interpretation, annotation, ACMG ranking, and causal variant prioritization. Their solutions are designed for research and clinical use, offering significant cost savings, enhanced data security, and up to 100-fold increase in throughput compared to manual methods.
Company Info
- Founded
- 2015
- Website
- omnitier.com/
Categories
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of OmniTier?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.